Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp > Setting up for new lows

<< Previous

Bullboard Posts

Next >>

Comment by Pandoraon Nov 16, 2022 12:28am

83 Views

Post# 35102073

RE:RE:RE:RE:Setting up for new lows

hcdtrading wrote: Ahh I guess the SBM cheques are not bouncing yet, BIO still has his job as stockhouse pumper.
Also I dont do TA, it is just looking at past lows and new lows getting taken out, plus the trend. The trend has been bear since about July. This stock could easily see single digits again and possibly this week it will. Oh, but what about the pet deal that is coming. That will save the stock just like all the other "deals" did.

The ABBVIE deal should have been a door opener. It's got the big name and the market scope but it went through like a dead fish. Why was that? How did everyone but us know it was a dud?

<< Previous

Bullboard Posts

Next >>

Changing Europe’s dependency on HREE from China